MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4149/bll_2020_115

Медицинская библиотека · Bratislavske lekarske listy · 2020

How do arbidol and its analogs inhibit the SARS-CoV-2?

Aktas A, Tuzun B, Taskin A H, Sayin K, Ataseven H

СтатьяПеревод в очереди

Аннотация

BACKGROUND

COVID-19 is not fully known and causes severe inflammation and cytokine storm. It has many symptoms, such as: fever, sore throat, headache, dyspnoea, and diarrhoea. Arbidol was used in the treatment of COVID19, which was the most critical health problem in the world. However, the desired recovery was not achieved with Arbidol. Many countries still use this drug in the treatment of COVID19.

AIM: We aimed to determine whether Arbidol, the hemagglutinin esterase inhibitor used in the treatment of COVID-19, was effective against SARS Cov-2 in silico.

RESULTS AND

CONCLUSION

The similarity between hemagglutinin and spike proteins were reported due to the fact that inhibition properties of Arbidol and its 39 analogues were examined in detail against hemagglutinin esterase and spike glycoproteins. CID 1070884 and CID 1207786 were found to be more active against hemagglutinin esterase than in Arbidol, while these compounds were inactive against spike glycoproteins. The interaction mechanism was clarified between arbidol and spike proteins. Phenylalanine, tyrosine, glycine, lysine, and aspartic acid were found to be the headliner amino acids in the interactions between Arbidol and binding domains of spike glycoproteins in the SARS-CoV2 (Tab. 3, Fig. 8, Ref. 28).

Для цитирования: Aktas A, Tuzun B, Taskin A H, Sayin K, Ataseven H. How do arbidol and its analogs inhibit the SARS-CoV-2?. Bratislavske lekarske listy. 2020. DOI: 10.4149/bll_2020_115.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.